Abstract
mTOR, as a serine/threonine kinase, is a widely pursued anticancer target. Multiple clinical trials of mTOR kinase inhibitors are ongoing, but their s......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
